Related Experiment Video
Updated: Jun 9, 2025

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
[Clinical Application of Two Bleeding Scoring Scales in Children with Primary Immune Thrombocytopenia]
Fu Liu1,2, Chun-Yan DU2, Tao Hu2
1Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Sichuan Clinical Research Center for Birth Defects, Luzhou 646000, Sichuan Province, China.
Insights
The 2019 Pediatric ITP Scale effectively assesses bleeding in children with immune thrombocytopenia (ITP). This scale shows good consistency and sensitivity, making it a valuable tool for disease management.
Area of Science:
- Hematology
- Pediatric Medicine
- Clinical Diagnostics
Context:
- Primary immune thrombocytopenia (ITP) is a bleeding disorder affecting children.
- Accurate assessment of bleeding severity is crucial for effective ITP management.
- Existing bleeding scoring scales require validation for pediatric populations.
Purpose:
- To evaluate the clinical utility of the 2019 Pediatric ITP Scale in diagnosing and managing pediatric primary ITP.
- To compare the 2019 Pediatric ITP Scale with the 2013 ITP-BAT in terms of consistency, time efficiency, and responsiveness to treatment.
Summary:
- The 2019 Pediatric ITP Scale demonstrated good consistency (rs=0.7638) and sensitivity in assessing bleeding in 422 children with ITP.
- The scale showed a significant negative correlation with platelet counts and was quicker to administer (88.64s vs 104.12s) than the 2013 ITP-BAT.
- The 2019 Pediatric ITP Scale effectively reflected treatment response, showing significant changes in scores post-treatment across different therapeutic groups.
Impact:
- The 2019 Pediatric ITP Scale is a reliable and efficient tool for disease assessment and efficacy determination in pediatric primary ITP.
- Its ease of use and validated accuracy can improve clinical decision-making and patient outcomes in pediatric hematology.
- This scale facilitates standardized bleeding assessment, aiding in comparative studies and treatment guideline development.
Objective:
To explore the clinical application value of the Bleeding Scoring Scales (2019 Pediatric ITP Scale) in the diagnosis and treatment of children with primary immune thrombocytopenia (ITP).
Methods:
A total of 422 children with ITP were evaluated with the 2019 Pediatric ITP Scale and the 2013 ITP-BAT and their clinical data were analyzed. The correlation between the two bleeding scoring scales and disease stage, platelet count was analysed, the evaluation time, consistency of the two bleeding scoring scales was compared, and the correlation of the two methods. The changes of platelet count and the score of 2019 Pediatric ITP Scale before treatment and after treatment at 48 h and one week were analyzed to detect responsiveness of the 2019 Pediatric ITP Scale.
Results:
The score of the 2019 Pediatric ITP Scale was mainly one point and two points, the corresponding bleeding was skin and mucosal bleeding.404 patients (95.7%) had bleeding manifestations, including 249 patients of skin bleeding (59.0%), 144 patients of mucosal bleeding (34.1%), and 11 patients of organ bleeding (2.6%), of which 2 patients were severe bleeding. The two bleeding scoring scales were both negatively correlated with platelet counts in children with ITP (r s=-0.5032, r s=-0.6084) and no correlation with the stage of pediatric ITP(P >0.05). The 2019 Pediatric ITP Scale had good consistency with the 2013 ITP-BAT (r s=0.7638). The average time required for the 2019 Pediatric ITP Scale was 88.64 (40-181) seconds, which was lower than that required for the 2013 ITP-BAT 104.12 (47-285) seconds (Z =17.792, P < 0.001). The 2019 Pediatric ITP Scale can well reflect the treatment of pediatric ITP. There were statistically significant differences in platelet count before treatment and after treatment at 48 h and one week among steroid group, IVIG group and steroid combined with IVIG group ( P < 0.05). There were also statistically significant differences in the score of the 2019 Pediatric ITP Scale before treatment and after treatment at one week among the three groups ( P < 0.05).
Conclusion:
The 2019 Pediatric ITP Scale has good consistency and sensitivity in clinical application, and it takes less time to complete than the 2013 ITP-BAT, this scale can be used as an effective tool for disease assessment and efficacy determination in pediatric primary immune thrombocytopenia.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

